Abstract

AbstractPost‐transplant lymphoproliferative disease (PTLD) is a rare but potentially fatal complication of organ transplanta‐tion. Most cases of PTLD represent Epstein Barr virus (EBV)‐related B‐cell disease in a setting of pharmacological immunosuppression. Post‐transplant plasma cell dyscrasia is very rare, and post‐transplant plasma cell dyscrasia with extramedullary plasmacytoma is extremely rare. We report here a case of the latter, which to our knowledge is the fourth such reported case in the English literature. A 22‐year‐old man developed post‐transplant plasma cell dyscrasia 20 years after a renal transplant while on immunosuppression. His presentation included retroperitoneal plasmacytoma, which is very rare and is probably the first case in a renal transplant patient. The patient is in complete remission 1 year after receiving five cycles of bortezomib and dexamethasone.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call